Qosina, a global supplier of OEM single-use components to the medical and bioprocess industries, has added over 250 new products to its portfolio in the first half of 2025. As part of its commitment to innovation, speed to market and customer-driven solutions, the company plans to add 500 more products before the end of the year.
This expansion reinforces Qosina’s commitment to offering one of the industry’s broadest selections of single-use components. The new products—including tubing, stopcocks and manifolds, bag ports, check valves and connectors—are designed to meet the evolving needs of engineers, designers and procurement teams in both medical device manufacturing and bioprocessing as they drive development and scale production.
“As our customers continue to innovate, we remain focused on enhancing our portfolio with the components they need—when and where they need them,” said Lee Pochter, CEO of Qosina. “Our growing product catalog underscores our mission to simplify the component sourcing process and support customers across the full lifecycle of development and production.”
With more than 5,000 SKUs in stock and a robust pipeline of new additions, Qosina continues to deliver the breadth and reliability that medical device and bioprocess OEMs depend on. This ongoing expansion reflects Qosina’s commitment to simplifying sourcing and supporting customers from prototype through production.
